Search
Search Results
##search.searchResults.foundPlural##
-
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2244PDF: 885HTML: 2001Fig 1 Rossi: 177 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1636PDF: 1093HTML: 119 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1358PDF: 469HTML: 173 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1620PDF: 901HTML: 1877Untitled: 195Untitled: 179 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1680PDF: 1442HTML: 245 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4122PDF: 1946HTML: 1764 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1390PDF: 877HTML: 7948Untitled: 200 -
SICKLE CELL ANAEMIA AND MALARIA
11439PDF: 7002HTML: 23882Figures Malaria and SCK: 213 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2220PDF: 942HTML: 6784Figure 1: 170 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
819PDF: 540HTML: 4019 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4367PDF: 909HTML: 1325Table1: 181 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1773PDF: 938HTML: 1111Untitled: 152Untitled: 170Untitled: 157Untitled: 158 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3221PDF: 1433HTML: 5848Fig1-Ag-Pil: 226Ag-Pil Fig.2: 228 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2131PDF: 1694HTML: 378 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3612PDF: 1108HTML: 23338 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2103PDF: 993HTML: 4070Cover Letter: 221Figure 1: 233Figure 2: 230Table 1: 204 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3268PDF: 1095HTML: 438 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1321PDF: 1129HTML: 119 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2024PDF: 1053HTML: 716Figure 1: 155Figure 2: 169 -
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3588PDF: 886HTML: 6711 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2294PDF: 1326HTML: 17079Bassan Fig.1: 143Bassan Fig.2: 155Bassan Fig.4: 142Fig.3: 185 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1383PDF: 922HTML: 1653Figure 1: 178 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1944PDF: 1166HTML: 267 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3153PDF: 1115HTML: 1757 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2271PDF: 994HTML: 148Suppl. Files: 512 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4426PDF: 1638HTML: 3672Tables and Images: 220 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1720PDF: 839HTML: 148 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1243PDF: 649HTML: 7727 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2825PDF: 951HTML: 7334 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3995PDF: 1052HTML: 3592Untitled: 177Cneo. Fig.1: 114Untitled: 104Untitled: 126Untitled: 132







